Yvonne Chen

Yvonne Chen has engineered multi-specific CAR-T cells that target multiple tumor antigens simultaneously to prevent antigen escape, a major mechanism of cancer resistance to cell therapy. Her bivalent and trivalent CAR designs have demonstrated superior efficacy in glioblastoma models. She has advanced structural engineering approaches that optimize CAR signaling and T cell fitness for durable anti-tumor responses.